This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2025
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2025 | 990 | $4,671,069 | $6,171,537 | $3,092,451 | $20,002,839 | $16,728,703 |
| FY2024 | 990 | $4,255,766 | $5,238,185 | $1,321,355 | $21,495,900 | $17,036,445 |
| FY2023 | 990 | $3,641,953 | $5,574,158 | $2,130,495 | $22,252,031 | $17,330,930 |
| FY2022 | 990 | $3,972,441 | $4,263,330 | $1,365,339 | $22,322,488 | $18,446,798 |
| FY2021 | 990 | $3,855,378 | $3,507,955 | $1,144,615 | $25,903,586 | $21,759,375 |
| FY2020 | 990 | $4,436,812 | $5,424,944 | $2,898,801 | $23,173,135 | $18,662,413 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 85% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| The Curators of the University of MissouriColumbia, MO | Characterization of Graft Types for Acetabular Labrum Reconstruction | $100,000 | 2023 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Joshua J Jacobs Md | President | 5.00 | $0 |
| Thomas P Sculco Md | Past President | 5.00 | $0 |
| Richard F Kyle Md | Past President | 5.00 | $0 |
| Andrew N Pollak Md | President Elect |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| University of WashingtonSeattle, WA |
| Magnetic Microgels for Composite Musculoskeletal Tissue Regeneration |
| $100,000 |
| 2024 |
| Steadman Philippon Research InstituteVail, CO | Understanding Contribution of Senescent Cells to Rate of Fracture Repair | $99,999 | 2022 |
| The Pennsylvania State University College of MedicineHershey, PA | Mechanobiological Deficits in Allograft ACL Reconstructions | $98,000 | 2020 |
| The Regents of the University of California San Francisco (Contracts & GraSan Francisco, CA | The Use of Venlafaxine in Reducing Surgical Pain in Total Knee Arthroplasty | $55,000 | 2021 |
| Duke University School of MedicineDurham, NC | Quantitative MRI of Glenohumeral Cartilage & Labrum in Shoulder Instability | $50,000 | 2022 |
| The University of IowaIowa City, IA | Regional Nerve Blocks to Improve Recovery in Elderly Spinal Fusion Patients | $50,000 | 2023 |
| Cleveland Clinic FoundationCleveland, OH | Characterizing Cartilage Degradation Caused by Patellar Instability | $50,000 | 2020 |
| The Hospital for Special SurgeryNew York, NY | The Role of Cellular Senescence in Joint Stiffness | $50,000 | 2025 |
| The Hospital for Special SurgeryNew York, NY | PRP treatment of the ACL-injured knee to decrease the risk of PTOA | $50,000 | 2021 |
| The Hospital for Special SurgeryNew York, NY | Characterizing the effects of corticosteroids in rotator cuff tendinopathy | $50,000 | 2024 |
| The Regents of the University of California Los AngelesLos Angeles, CA | Functional Impact of Intra-articular ALK1-Fc Therapy in Osteoarthritis | $50,000 | 2023 |
| Oregon Health & Science UniversityPortland, OR | Quantification of fracture healing biology using novel collagen X bioassay | $50,000 | 2020 |
| University of Maryland BaltimoreBaltimore, MD | The Role of CCN2 in Tendon Healing | $50,000 | 2023 |
| Medical Technology Enterprise Consortium - The Henry Jackson Foundation forSummerville, SC | Dynamic Gait-Synchronous Neuromuscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction | $50,000 | 2024 |
| The Research Foundation for The SUNY on behalf of University at BuffaloAmherst, NY | Optimizing Antibiotic-Cement Efficacy in Peri Prosthetic Shoulder Infection | $50,000 | 2023 |
| MAYO CLINIC ROCHESTER MNRochester, MN | How Many Dexamethasone Doses Should Be Given in TKA? - A Prospective RT | $50,000 | 2025 |
| Washington University in StLouisSt Louis, MO | Patient factors associated with genetic markers for rotator cuff disease | $50,000 | 2020 |
| The Regents of the University of California Los AngelesLos Angeles, CA | BMP Receptor Ligand Traps as a Therapy for Post-traumatic Osteoarthritis | $50,000 | 2021 |
| Medical Technology Enterprise Consortium - The Geneva FoundationSummerville, SC | Objective Dynamic and 3D Knee Assessment Medical Device to Improve Recovery and Accelerate Return to Readiness of Members with Knee Pain | $50,000 | 2024 |
| The Regents of the University of California on Behalf of its Davis CampusDavis, CA | Decellularized Skeletal Muscle Matrix for Open Fractures with Muscle Loss | $50,000 | 2024 |
| Scottish Rite for ChildrenDallas, TX | Establishing a RTP test battery for patients post shoulder stabilization | $49,999 | 2025 |
| University of Southern California - Keck School of MedicineLos Angeles, CA | Efficacy of Dextromethorphan for Pain Management in Total Knee Arthroplasty | $49,985 | 2023 |
| The Regents of the University of California on Behalf of its Davis CampusDavis, CA | CHAT-OA: Conversations in Health-Literacy using AI for Osteoarthritis Pts | $49,908 | 2025 |
| The University of UtahSalt Lake City, UT | Synovial lining macrophages in OA: Defining their fate in obesity | $49,698 | 2025 |
| 5.00 |
| $0 |
| James R Ficke Md | 2nd President Elect | 5.00 | $0 |
| Karen L Hackett | Secretary / Treasurer | 5.00 | $0 |
| Francis Y Lee Md Phd | Chair RGC | 5.00 | $0 |
| Jeffrey S Abrams Md | Chair, Innovations & Partn | 5.00 | $0 |
| Richard F Santore Md | Chair-Individual Developme | 5.00 | $0 |
| Jeremie M Axe Md | Trustee | 5.00 | $0 |
| Nicholas M Bernthal Md | Trustee | 5.00 | $0 |
| Daniel J Berry Md | Trustee | 5.00 | $0 |
| Michael P Bolognesi Md | Trustee | 5.00 | $0 |
| John D Kelly Iv Md | Trustee | 5.00 | $0 |
| David C Templeman Md | Trustee | 5.00 | $0 |
| Ivan Tormos | Trustee | 5.00 | $0 |
| Stuart Weinstein Md | Trustee | 5.00 | $0 |
| Rhonda Dirr | Executive Director | 40.00 | $116,041 |
| Lee Grossman | CEO | 40.00 | $308,549 |
| Dan Krupp | Corporate Relations/Innova | 40.00 | $153,497 |
| Deborah Cummins | VP of Research and Grants | 40.00 | $150,845 |
| Carmen Metoyer | VP of Development | 40.00 | $105,098 |
| Karen Pubentz | Sr. Director of Communicat | 40.00 | $148,566 |
| John Johnson | Campaigns Director | 1.00 | $134,357 |
Form 990 · FY2024 · period ending Jun 30, 2024IRS bulk XML
Filing id 202501359349315215
Form 990 · FY2023 · period ending Jun 30, 2023IRS bulk XML
Filing id 202420469349302357
Form 990 · FY2022 · period ending Jun 30, 2022
Filing id 202301179349301015
Form 990 · FY2021 · period ending Jun 30, 2021
Filing id 202201029349301415
Form 990 · FY2020 · period ending Jun 30, 2020
Filing id 202111099349301301
Form 990 · FY2018 · period ending Jun 30, 2018
Filing id 201940709349300719
Form 990 · FY2016 · period ending Dec 31, 2016
Filing id 201703109349300005
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.